$ENOV News

BTIG Reiterates Buy on Enovis, Maintains $39 Price Target

Enovis Corporation 2026 Q1 - Results - Earnings Call Presentation

Evercore ISI Group Maintains Outperform on Enovis, Raises Price Target to $36

Wells Fargo Maintains Overweight on Enovis, Lowers Price Target to $40

Enovis Corporation (ENOV) Q1 2026 Earnings Call Transcript

Enovis Corp. (NYSE:ENOV) Beats Q1 Estimates, Reaffirms Guidance

Enovis Affirms FY2026 Adj EPS Guidance of $3.52-$3.73 vs $3.62 Est; Affirms FY2026 Sales Guidance of $2.310B-$2.370B vs $2.344B Est

Enovis Q1 Adj. EPS $0.89 Beats $0.82 Estimate, Sales $589.200M Beat $571.131M Estimate

Despite Fast-paced Momentum, Enovis (ENOV) Is Still a Bargain Stock

Does The Recent Rebound In Enovis (ENOV) Share Price Reflect Its True Worth?

Analyst Backs Enovis On Cash Flow Turnaround

Enovis to Host First Quarter 2026 Results Conference Call on May 7th

Evercore ISI Group Maintains Outperform on Enovis, Lowers Price Target to $35

Wall Street Analysts See a 100.71% Upside in Enovis (ENOV): Can the Stock Really Move This High?

How The Enovis (ENOV) Story Is Shifting Around Growth Margins And Cash Generation

Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks

Royce Small-Cap Fund FY 2025: What Worked... And What Didn't

Royce Premier Fund FY 2025: What Worked... And What Didn't

Wall Street Analysts Think Enovis (ENOV) Could Surge 76.62%: Read This Before Placing a Bet

Enovis Balances Revenue Growth And New Devices With Goodwill Impairment